Efavirenz (Sustiva, Stocrin)

Published January 25, 2001; Updated October 08, 2015
Susa Coffey, MD
Selected Reference
23. Raffi F, Esnault JL, Reliquet V, et al. The Maintavir Study, Substitution of a non-nucleoside reverse transcriptase inhibitor (NNRTI) for a protease inhibitor (PI) in patients with undetectable plasma HIV-1 RNA: 18 months follow-up. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17-20, 2000; Toronto. Abstract 474.